Here's Why This AI-Related Company's Stock Soared Today
Summarize this article with:
By Lee Samaha – Apr 30, 2026 at 2:12PM ESTKey PointsTeradyne's revenue is now 70% AI-driven, up from 60% last quarter, and eevenue grew 87% year-over-year, but second quarter guidance disappointed.Analysts from Goldman Sachs and JPMorgan took a positive view of the recent results. . Teradyne (TER +14.30%) shares shot higher by more than 15% as of 2 p.m. today as the market took a more positive view of its first quarter 2026 earnings report released on Tuesday. It's a fascinating situation for artificial intelligence (AI)- focused investors, not least because Teradyne CEO Gregory Smith described AI as "the dominant force shaping our business," accounting for "nearly 70% of our revenue, up from about 60% in Q4 of 2025" during the earnings call. Teradyne and the AI semiconductor cycle The company makes automated test equipment systems that assess a chip's functional capability. As AI chips become ever more complex and increasingly important to the global economy, and investment in AI continues to boom, Teradyne continues to see exceptional growth. Revenue grew an outstanding 87% year over year in the first quarter, but the stock slumped on Tuesday after management's second-quarter guidance disappointed investors. ExpandNASDAQ: TERTeradyneToday's Change(14.30%) $43.80Current Price$350.13Key Data PointsMarket Cap$48BDay's Range$327.04 - $353.3552wk Range$73.11 - $422.11Volume253KAvg Vol3.7MGross Margin58.64%Dividend Yield0.16% While the revenue guidance of $1.15 billion to $1.25 billion implies a 76% to 92% increase over the second quarter of 2025, it also implies a sequential decline from the $1.28 billion reported in the recent first quarter. That was enough to send the shares down sharply, as the market immediately began pricing in an inflection point in the company's revenue trajectory – also potentially bad news for AI investors. Why the stock recovered today Management argued that the implied sequential decline in revenue is more reflective of natural lumpiness in order timing than of any fundamental change in the marketplace. It also claimed its Vertically Integrated Producer (VIP) compute would be "really, really strong in the first half of the year," but the next generation of technology is "early" in 2027, making for uncertain demand in the second half of 2026. Image source: Getty Images. Two analysts at Wall Street heavyweight companies, Goldman Sachs and JPMorgan, sympathized with an analyst at the former, raising the price target to $350 from $300 while maintaining a buy rating, and one at the latter upgraded to overweight from neutral while maintaining a $400 price target. Read NextApr 30, 2026 •By Geoffrey SeilerBull vs. Bear: D-Wave QuantumApr 30, 2026 •By Danny Vena, CPACEO Sundar Pichai Just Delivered Incredible News For Alphabet (GOOGL) InvestorsApr 30, 2026 •By Bram BerkowitzIf New Apple CEO John Ternus Takes Anything Away From Tim Cook's Legendary 15-Year Run, It Should Be This $841 Billion LessonApr 30, 2026 •By James BrumleyWhy Qualcomm Stock Is Soaring on ThursdayApr 30, 2026 •By Keithen DruryThe Best Quantum Computing Stock to Buy Right NowApr 30, 2026 •By Bram Berkowitz"Magnificent Seven" Companies Microsoft, Amazon, Alphabet, and Meta Just Reported Earnings. Here Are the Winners and LosersAbout the AuthorLee Samaha is a contributing Stock Market Analyst at The Motley Fool covering industrials, electricals, energy, materials, transportation, and infrastructure stocks. Prior to The Motley Fool, Lee was a Civil Engineer and Investment Manager. He holds a Bachelor of Civil and Structural Engineering from Southampton University and a Certificate in Investment Management from Chartered Institute for Securities & Investment. Lee first cut his investing teeth on The Motley Fool bulletin boards (commonly referred to as the “Fool Boards,”) and he’s infinitely grateful to all of the investors he learned from in this powerful investing community.TMFSaintGermainX@LeeSamahaStocks MentionedGoldman Sachs GroupNYSE: GS$925.74(+2.22%)+$20.14JPMorgan ChaseNYSE: JPM$313.77(+1.46%)+$4.52TeradyneNASDAQ: TER$350.57(+14.44%)+$44.24*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.